全文获取类型
收费全文 | 3133篇 |
免费 | 88篇 |
国内免费 | 13篇 |
专业分类
系统科学 | 115篇 |
丛书文集 | 3篇 |
教育与普及 | 2篇 |
理论与方法论 | 26篇 |
现状及发展 | 1002篇 |
研究方法 | 30篇 |
综合类 | 2045篇 |
自然研究 | 11篇 |
出版年
2024年 | 17篇 |
2023年 | 27篇 |
2022年 | 9篇 |
2021年 | 6篇 |
2020年 | 12篇 |
2017年 | 9篇 |
2016年 | 28篇 |
2015年 | 54篇 |
2014年 | 27篇 |
2013年 | 21篇 |
2012年 | 143篇 |
2011年 | 157篇 |
2007年 | 9篇 |
2006年 | 12篇 |
2005年 | 198篇 |
2004年 | 504篇 |
2003年 | 466篇 |
2002年 | 140篇 |
2001年 | 75篇 |
2000年 | 138篇 |
1999年 | 75篇 |
1992年 | 37篇 |
1991年 | 25篇 |
1990年 | 35篇 |
1989年 | 34篇 |
1988年 | 32篇 |
1987年 | 16篇 |
1986年 | 26篇 |
1985年 | 35篇 |
1984年 | 26篇 |
1983年 | 24篇 |
1982年 | 15篇 |
1981年 | 11篇 |
1980年 | 17篇 |
1979年 | 61篇 |
1978年 | 39篇 |
1977年 | 31篇 |
1976年 | 29篇 |
1975年 | 38篇 |
1974年 | 56篇 |
1973年 | 50篇 |
1972年 | 50篇 |
1971年 | 66篇 |
1970年 | 54篇 |
1969年 | 68篇 |
1968年 | 59篇 |
1967年 | 41篇 |
1966年 | 56篇 |
1965年 | 41篇 |
1964年 | 11篇 |
排序方式: 共有3234条查询结果,搜索用时 531 毫秒
61.
Sieni E Cetica V Mastrodicasa E Pende D Moretta L Griffiths G Aricò M 《Cellular and molecular life sciences : CMLS》2012,69(1):29-40
Cytotoxic T lymphocytes, natural killer cells, and NKT cells are effector cells able to kill infected cells. In some inherited
human disorders, a defect in selected proteins involved in the cellular cytotoxicity mechanism results in specific clinical
syndromes, grouped under the name of familial hemophagocytic lymphohistiocytosis. Recent advances in genetic studies of these
patients has allowed the identification of different genetic subsets. Additional genetic immune deficiencies may also induce
a similar clinical picture. International cooperation and prospective trials resulted in refining the diagnostic and therapeutic
approach to these rare diseases with improved outcome but also with improved knowledge of the mechanisms underlying granule-mediated
cellular cytotoxicity in humans. 相似文献
62.
63.
Farooqui AA Farooqui T Panza F Frisardi V 《Cellular and molecular life sciences : CMLS》2012,69(5):741-762
The metabolic syndrome is a cluster of common pathologies: abdominal obesity linked to an excess of visceral fat, insulin
resistance, dyslipidemia and hypertension. At the molecular level, metabolic syndrome is accompanied not only by dysregulation
in the expression of adipokines (cytokines and chemokines), but also by alterations in levels of leptin, a peptide hormone
released by white adipose tissue. These changes modulate immune response and inflammation that lead to alterations in the
hypothalamic ‘bodyweight/appetite/satiety set point,’ resulting in the initiation and development of metabolic syndrome. Metabolic
syndrome is a risk factor for neurological disorders such as stroke, depression and Alzheimer’s disease. The molecular mechanism
underlying the mirror relationship between metabolic syndrome and neurological disorders is not fully understood. However,
it is becoming increasingly evident that all cellular and biochemical alterations observed in metabolic syndrome like impairment
of endothelial cell function, abnormality in essential fatty acid metabolism and alterations in lipid mediators along with
abnormal insulin/leptin signaling may represent a pathological bridge between metabolic syndrome and neurological disorders
such as stroke, Alzheimer’s disease and depression. The purpose of this review is not only to describe the involvement of
brain in the pathogenesis of metabolic syndrome, but also to link the pathogenesis of metabolic syndrome with neurochemical
changes in stroke, Alzheimer’s disease and depression to a wider audience of neuroscientists with the hope that this discussion
will initiate more studies on the relationship between metabolic syndrome and neurological disorders. 相似文献
64.
65.
Altenhöfer S Kleikers PW Radermacher KA Scheurer P Rob Hermans JJ Schiffers P Ho H Wingler K Schmidt HH 《Cellular and molecular life sciences : CMLS》2012,69(14):2327-2343
Reactive oxygen species (ROS) are cellular signals but also disease triggers; their relative excess (oxidative stress) or shortage (reductive stress) compared to reducing equivalents are potentially deleterious. This may explain why antioxidants fail to combat diseases that correlate with oxidative stress. Instead, targeting of disease-relevant enzymatic ROS sources that leaves physiological ROS signaling unaffected may be more beneficial. NADPH oxidases are the only known enzyme family with the sole function to produce ROS. Of the catalytic NADPH oxidase subunits (NOX), NOX4 is the most widely distributed isoform. We provide here a critical review of the currently available experimental tools to assess the role of NOX and especially NOX4, i.e. knock-out mice, siRNAs, antibodies, and pharmacological inhibitors. We then focus on the characterization of the small molecule NADPH oxidase inhibitor, VAS2870, in vitro and in vivo, its specificity, selectivity, and possible mechanism of action. Finally, we discuss the validation of NOX4 as a potential therapeutic target for indications including stroke, heart failure, and fibrosis. 相似文献
66.
67.
Gutiérrez-López MD Gilsanz A Yáñez-Mó M Ovalle S Lafuente EM Domínguez C Monk PN González-Alvaro I Sánchez-Madrid F Cabañas C 《Cellular and molecular life sciences : CMLS》2011,68(19):3275-3292
ADAM17/TACE is a metalloproteinase responsible for the shedding of the proinflammatory cytokine TNF-α and many other cell
surface proteins involved in development, cell adhesion, migration, differentiation, and proliferation. Despite the important
biological function of ADAM17, the mechanisms of regulation of its metalloproteinase activity remain largely unknown. We report
here that the tetraspanin CD9 and ADAM17 partially co-localize on the surface of endothelial and monocytic cells. In situ
proximity ligation, co-immunoprecipitation, crosslinking, and pull-down experiments collectively demonstrate a direct association
between these molecules. Functional studies reveal that treatment with CD9-specific antibodies or neoexpression of CD9 exert
negative regulatory effects on ADAM17 sheddase activity. Conversely, CD9 silencing increased the activity of ADAM17 against
its substrates TNF-α and ICAM-1. Taken together, our results show that CD9 associates with ADAM17 and, through this interaction,
negatively regulates the sheddase activity of ADAM17. 相似文献
68.
69.
70.
Amiot L Ferrone S Grosse-Wilde H Seliger B 《Cellular and molecular life sciences : CMLS》2011,68(3):417-431
Although the expression of the non-classical HLA class I molecule HLA-G was first reported to be restricted to the fetal–maternal
interface on the extravillous cytotrophoblasts, the distribution of HLA-G in normal tissues appears broader than originally
described. HLA-G expression was found in embryonic tissues, in adult immune privileged organs, and in cells of the hematopoietic
lineage. More interestingly, under pathophysiological conditions HLA-G antigens may be expressed on various types of malignant
cells suggesting that HLA-G antigen expression is one strategy used by tumor cells to escape immune surveillance. In this
article, we will focus on HLA-G expression in cancers of distinct histology and its association with the clinical course of
diseases, on the underlying molecular mechanisms of impaired HLA-G expression, on the immune tolerant function of HLA-G in
tumors, and on the use of membrane-bound and soluble HLA-G as a diagnostic or prognostic biomarker to identify tumors and
to monitor disease stage, as well as on the use of HLA-G as a novel therapeutic target in cancer. 相似文献